Evidence map›Paper›PMID 32888170›Full record

ArticleJournal of racial and ethnic health disparities2021

Patterns of Failure in Triple Negative Breast Cancer Patients in an Urban, Predominately Black Population.

Hua-Ren Cherng, Stephanie R Rice, Muhammad Hamza, Shruti Murali, Paula Rosenblatt, Katherine H R Tkaczuk, Emily Bellavance, Sally Cheston, Neha Amin, Elizabeth Nichols

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of racial and ethnic health disparities, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Hua-Ren Cherng *Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USA.
Stephanie R Rice *Department of Radiation Oncology, University of Maryland Medical Center, Baltimore, MD, USA. steph.rice10@gmail.com.ORCID http://orcid.org/0000-0002-2661-935X
Muhammad HamzaDepartment of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USA.
Shruti MuraliDivision of Hematology/Oncology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Paula RosenblattDivision of Hematology/Oncology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Katherine H R TkaczukDivision of Hematology/Oncology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Emily BellavanceDepartment of Surgical Oncology, University of Maryland School of Medicine, Baltimore, MD, USA.
Sally ChestonDepartment of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USA.
Neha AminDepartment of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USA.
Elizabeth NicholsDepartment of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USA.
University of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Triple negative breast cancers (TNBC) behave more aggressively than hormone-receptor positive breast cancers. They are also known preferentially to affect young black women, often leading to poorer outcomes compared with those for white women. We sought to evaluate the comprehensive patterns of failure associated with treatment for TNBC at an urban institution with a predominantly black population and to assess the impact of social determinants of health on treatment failure. A retrospective review of TNBC patients treated from 2005 to 2015 was conducted. Detailed patient, tumor, and treatment characteristics and information on patterns of failure were included. With a median follow-up of 46 months, 32 (16%) documented failures occurred. Locoregional failures comprised 84% of failure patterns whether isolated or in combination with distant failure. Treatment failure was associated with insurance type and smoking status, as well as several tumor characteristics. On multivariate analysis, pathologic nodal staging was the most significant predictor of treatment failure. In contrast to previous studies, we found that black women had higher overall survival than white women, but race was not associated with differences in recurrence patterns or with likelihood of treatment failure. Regardless of race, of the patients who recurred, 53% failed in distant and locoregional sites simultaneously, with an additional 34% failing locally only. These results highlight the need for aggressive local therapies in high-risk patients and suggest a need for improved follow-up focusing on detecting locoregional failures. Multidisciplinary care is essential in the management of these patients at time of failure.

Indexed as

Treatment FailureAdultAgedAged, 80 and overBlack or African AmericanFemaleHealth Status DisparitiesHumansMiddle AgedRetrospective StudiesTriple Negative Breast NeoplasmsUrban PopulationYoung AdultBreast cancerFailurePatternsPredictorsSocial determinantsTriple negative

Identifiers

PMID32888170
OpenAlexW3083006814

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.